Nachrichten [1234]
Select category
Pharmaceutical News
- 2009 [31]
- 2008 [1203]

Pharmaceutical News

European Forum For Industrial Biotechnology, Brussels, Belgium, 15-17 September
Wed, 30 July 2008
The European Forum for Industrial Biotechnology 2008 (EFIB2008) will take place from 15 to 17 September in Brussels, Belgium. Organised by EuropaBio (the European Association for Bioindustries) and IntertechPira, the event will feature two workshops, networking sessions and a two-day forum with approximately 30 leading s ...
Idenix Pharmaceuticals Advances HCV Discovery Program To Clinic
Wed, 30 July 2008
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced that it has initiated a first-in-man study of IDX184 under a United States investigational new drug (IND) applica ...
FDA Advisory Committee Recommends Approval Of ACTEMRA(R) (tocilizumab) For The Treatment ...
Wed, 30 July 2008
Roche announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by a near unanimous (10-1) vote recommended approval of ACTEMRA(R) (tocilizumab), a novel interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody, for reducing the signs and symptoms in adults with moderate to ...
ICON Enhances Its ICOPhone Technology Platform - New EPRO Module Reduces Implementation ...
Wed, 30 July 2008
ICON plc (NASDAQ: ICLR; ISIN: IE0001827041) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the release of an enhanced version of ICOPhone?, ICON's technology platform for the delivery of Voice and Web Response (IVR/IWR) services.
Sea Lane Biotechnologies Unveils A Potential New Class Of Biotherapeutics
Wed, 30 July 2008
Sea Lane Biotechnologies, LLC (Sea Lane) announced the first demonstration of a new class of biotherapeutic molecules called Surrobodies? with the potential to impart transformative new abilities and benefits into next generation biologic treatments. Surrobodies build upon the increasing success of biotherapeutic antibodie ...
FDA Issues Not Approvable Letter For Iloperidone For The Treatment Of Schizophrenia To V ...
Wed, 30 July 2008
Titan Pharmaceuticals, Inc. (AMEX:TTP) announced that Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) has received a not approvable letter for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia, from the U.S. Food and Drug Administration (FDA). Vanda, the sub-licensee for iloperidone, is resp ...
BRIDION(R) (sugammadex) Injection - First And Only Selective Relaxant Binding Agent - Ap ...
Wed, 30 July 2008
Schering-Plough Corporation (NYSE: SGP) announced that the European Commission (EC) has approved BRIDION(R) (sugammadex) injection, the first and only selective relaxant binding agent (SRBA) and the first major pharmaceutical advance in the field of anesthesia in two decades.
FDA Poorly Equipped To Enforce Off-Label Prescription Drug Marketing Rules, GAO Report Finds
Wed, 30 July 2008
FDA takes an average of seven months to issue warnings to pharmaceutical companies that market medications for off-label uses, and those companies take an average of four months to address the violations, according to a draft report compiled by the Government Accountability Office, the
Upstream Begins Animal Efficacy Testing For Leishmaniasis Treatment
Wed, 30 July 2008
Upstream Biosciences Inc. (OTCBB: UPBS) announced that it is collaborating with Makerere University in Kampala, Uganda to evaluate the efficacy in animals of more than 20 proprietary drug candidates as potential treatments for Leishmaniasis in humans. Drug resistance has greatly reduced the effectiveness of existing Leishman ...
Polyphenon Pharma Receives Orphan Drug Designation For Its Botanical Drug, Polyphenon E, ...
Wed, 30 July 2008
Polyphenon Pharma, an emerging research-based pharmaceutical company, announced that the Food and Drug Administration (FDA) has granted Orphan Drug Designation to its botanical drug, Polyphenon E(R), for the treatment of chronic lymphocytic leukemia (CLL). A Phase II study is currently underway at the Mayo Clinic i ...

Advertisements

Nachrichten

This section contains news related to the pharmazeutisch industry.

Publishers of pharmazeutisch related news can register for free on our website and add their pharmazeutisch news to this website.

Advertisements

Unsere Webseiten

Chemicals 1.com

Feed Additives 1.com

Medical Products 1.com

Medicines 1.com

Pet Products 1.com

Veterinary Products 1.com

mehr 1.com Webseiten

- Über uns
- Über Pharmaceuticals 1.com
- Email senden
- Nutzungsbedingungen
- Using Pharmaceuticals 1.com
- Register (free) / Join now
- Mitgliedschaften
- How to buy/sell
- FAQ / Help

Pharmaceutical News - july 2008

Members in

Copyright (c) 2003 - 2009 by Business Portals BV